Fig. 19From: Predicted antiviral drugs Darunavir, Amprenavir, Rimantadine and Saquinavir can potentially bind to neutralize SARS-CoV-2 conserved proteinsActive site residues & drug binding motifs of NSP16. a–c Different surface projections showing inhibitory association of drug binding motifs with active site residues of the enzyme. 478-Amprenavir; 017-Darunavir; RIM Rimantadine, ROC SaquinavirBack to article page